Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease

Eur Neurol. 2010;63(3):176-9. doi: 10.1159/000289097. Epub 2010 Feb 27.

Abstract

A higher risk of suicidal attempt after subthalamic nucleus deep brain stimulation (STN-DBS) for Parkinson's disease (PD) has been consistently reported. We retrospectively analyzed 3 PD patients with suicide attempts after STN-DBS. All patients had normal pre- and immediate postoperative psychopathological and cognitive evaluations, with STN-DBS yielding a good motor benefit. Levodopa medication was markedly reduced. Albeit there was a significant reduction in dopaminergic medication, there was also a considerable time lag to suicide attempt. Impulsive behavior could have played a higher role, going unnoticed in punctual psychopathological examinations. STN-DBS patients need a closer postoperative psychiatric and behavioral follow-up.

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Deep Brain Stimulation / adverse effects*
  • Female
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / psychology*
  • Parkinson Disease / therapy*
  • Subthalamic Nucleus / physiology*
  • Suicide / psychology*

Substances

  • Antiparkinson Agents
  • Levodopa